U.S. Renewable Energy Stock News

NYSE:KKR
NYSE:KKRCapital Markets

KKR’s DCC Bid Tests Private Equity’s Appetite For European Energy Assets

KKR (NYSE:KKR) is leading a consortium in advanced talks to acquire DCC in a deal valued at over £5b. The potential transaction would be one of the largest European energy distribution deals in 2026. The consortium has reportedly sweetened its offer as negotiations progress. For you as an investor, this deal sits at the intersection of private equity and energy infrastructure, an area drawing more attention as capital targets utilities and distribution assets. KKR is already a large global...
NYSE:WSO
NYSE:WSOTrade Distributors

Dividend Hike And Efficiency Push Might Change The Case For Investing In Watsco (WSO)

In recent weeks, Watsco has attracted attention as analysts and investors highlighted its leadership in HVAC distribution, robust balance sheet, and a 10% dividend increase that management approved earlier this year. These developments, alongside commentary on its perceived undervaluation and tariff-related risks, have reshaped how the market assesses the company’s current fundamentals. One particularly interesting angle is how Watsco’s ongoing acquisition program and focus on...
NYSE:BRO
NYSE:BROInsurance

Brown And Brown Targets Deal Growth With New Tax Insurance Leader

Brown & Brown (NYSE:BRO) has appointed Corey Lewis as Global Head of Tax Insurance. The new role focuses on expanding transactional tax insurance solutions across private equity and M&A services. This move is intended to build out the company’s capabilities in a specialized segment of the insurance market. For you as an investor, this update sits squarely in Brown & Brown’s core business of insurance brokerage and risk solutions, but in a focused niche. Transactional tax insurance is...
NYSE:M
NYSE:MMultiline Retail

Is It Too Late To Consider Macy's (M) After Its 99% One Year Surge?

Considering whether Macy's at around US$23.16 still offers value, or if most of the opportunity is already reflected in the price. The stock has returned 6.2% over the past week, 23.9% over the last month, 1.8% year to date, and 99.2% over the past year. These figures may influence how you think about both upside and risk. Recent headlines have focused on Macy's as a turnaround story and on investor interest in potential changes to its store footprint and real estate usage. There has also...
NYSE:APH
NYSE:APHElectronic

Is It Too Late To Consider Amphenol (APH) After Its 61% One Year Surge?

Wondering if Amphenol at US$149.22 is still offering fair value or if expectations are already priced in? This breakdown will help you put the current share price in context. The stock has returned 1.1% over the past week, 21.8% over the past month, 6.8% year to date, and 61.5% over the last year, which naturally raises questions about how much of the story is already reflected in the price. Recent coverage has focused on Amphenol as a large US connector supplier that is often used as a...
NasdaqGS:AMD
NasdaqGS:AMDSemiconductor

Is It Too Late To Consider Buying AMD (AMD) After Its Recent Pullback And AI Surge?

Wondering if Advanced Micro Devices at around US$452 per share is still offering value or if most of the opportunity is already priced in? This article focuses squarely on what the current valuation is really saying. The stock has pulled back around 16.6% over the past week and is down about 1.4% over the past month. It still stands up strongly with a 102.4% return year to date and 273.5% over the last year. Recent headlines have focused on Advanced Micro Devices as a key player in high...
NYSE:PR
NYSE:PROil and Gas

Middle East Tensions Test Permian Resources Exposure To Global Oil Prices

Permian Resources (NYSE:PR) is being affected by escalating conflict in the Middle East and U.S. military action related to Iran. Partial closure of the Strait of Hormuz is disrupting oil flows and contributing to sharp oil price swings. These developments are creating new supply and pricing risks for global energy markets beyond routine company updates. Permian Resources focuses on oil and gas production from the Permian Basin, so shifts in global supply routes and benchmark prices can...
NYSE:CHWY
NYSE:CHWYSpecialty Retail

Chewy (CHWY) Q1 EPS Jump Tests Bullish Margin Expansion Narrative

Chewy (CHWY) opened Q1 2027 with revenue of about US$3.4b and net income of US$94.8m, translating to basic EPS of US$0.23, setting a clear benchmark for how the pet retailer is currently converting sales into profit. The company reported revenue of US$3.1b in Q1 2026 and US$3.4b in Q1 2027, while basic EPS over the same quarters moved from US$0.15 to US$0.23, against a backdrop of trailing earnings growth and a current share price around US$19.98. For investors, a central question is how...
NYSE:MTZ
NYSE:MTZConstruction

A Look At MasTec (MTZ) Valuation After Recent Share Price Pullback

MasTec overview after recent trading moves MasTec (MTZ) has drawn attention after a recent pullback in the stock, with shares down about 5% over the past day and 9% over the past week, despite strong year to date gains. See our latest analysis for MasTec. Despite the recent pullback, MasTec’s 1 day, 7 day and 30 day share price returns of down 4.96%, 9.22% and 20.36% respectively sit against a year to date share price return of 47.41% and a 1 year total shareholder return of 106%. This...
NYSE:DEC
NYSE:DECOil and Gas

Unanimous Analyst Upgrades in Earnings Outlook Could Be A Game Changer For Diversified Energy (DEC)

In recent days, Wall Street analysts have reiterated a Strong Buy consensus on Diversified Energy, with all 10 covering firms assigning their most positive rating and raising earnings estimates. This unanimous stance highlights how shifting analyst expectations about Diversified Energy’s earnings potential can rapidly influence how the company is perceived by the broader market. Next, we’ll examine how this broad-based upgrade in earnings expectations could influence Diversified Energy’s...
NYSE:CMG
NYSE:CMGHospitality

Chipotle Matchday BOGO And Soccer Jersey Test Stock Value And Loyalty

Chipotle Mexican Grill (NYSE:CMG) is rolling out its first Matchday BOGO promotion on June 11. Customers wearing any soccer jersey can receive a buy one, get one free entrée in the U.S., Canada, and U.K. The company is also releasing a limited-edition soccer jersey available to loyalty members. For investors tracking NYSE:CMG, this campaign arrives with the stock at $30.42 and a 5.8% gain over the past week, alongside a 9.9% return over the past 5 years. Over shorter periods the share price...
NasdaqGS:NWBI
NasdaqGS:NWBIBanks

A Look At Northwest Bancshares (NWBI) Valuation After Recent Share Price Momentum And Conflicting Fair Value Estimates

Northwest Bancshares overview after recent performance Northwest Bancshares (NWBI) has drawn fresh attention as investors look at its recent share performance alongside its role as a regional bank serving Pennsylvania, New York, Ohio, and Indiana. See our latest analysis for Northwest Bancshares. The recent move in Northwest Bancshares' share price, with a 1-day share price return of 1.18% and a 90-day share price return of 18.86%, sits on top of a 1-year total shareholder return of 24.11%...
NYSE:AU
NYSE:AUMetals and Mining

Why AngloGold Ashanti (AU) Is Down 12.7% After Valuation Disconnect And Risk Reassessment - And What's Next

In recent weeks, AngloGold Ashanti has experienced a sharp pullback despite earlier strong multi‑year returns, as investors reassess the company against Discounted Cash Flow and Price‑to‑Earnings analyses that suggest it may be trading below its estimated intrinsic value and industry comparisons. This divergence between valuation models and market sentiment highlights how concerns over rising operating costs and geopolitical exposure can weigh on a business even when fundamentals appear...
NYSE:CRC
NYSE:CRCOil and Gas

A Look At California Resources (CRC) Valuation After Recent Share Price Cooling

What recent performance says about California Resources (CRC) California Resources (CRC) has drawn investor attention after recent trading, with the stock last closing at US$58.87 and showing mixed short term performance, including a gain of about 0.7% over the past day. See our latest analysis for California Resources. That small 1 day gain comes after a softer patch, with the 7 day share price return down 5.35%, the 30 day share price return down 1.36% and the year to date share price...
NYSE:ACVA
NYSE:ACVACommercial Services

Can ACV Auctions’ (ACVA) New Services Offset Softer Guidance And Macro Pressures On Its Digital Model?

In recent weeks, ACV Auctions’ annual meeting reaffirmed its existing board and auditor while management highlighted ongoing macroeconomic pressures, higher Treasury yields, and softer revenue guidance alongside cost structure concerns. The spotlight is now on newer services like ACV MAX and VIPER, which investors see as potential offsets to these headwinds despite the uncertain backdrop. We’ll now examine how softer revenue guidance and macro pressures interplay with ACV Auctions’...
NYSE:HAE
NYSE:HAEMedical Equipment

Is Haemonetics’ (HAE) Apheresis Reorg Quietly Redefining Its Competitive Edge in Medical Devices?

In recent days, Haemonetics Corporation saw increased attention as sector-wide interest in medical devices coincided with internal changes, including areshaped reporting segments and updated leadership compensation estimates for President and CEO Christopher A. Simon of US$12,044,701 for 2026. Investors are weighing this mix of sector momentum, perceptions of modest undervaluation, and Haemonetics’ consolidation of its Plasma and Blood Center units into a single Apheresis segment as they...
NasdaqGS:IONS
NasdaqGS:IONSBiotechs

Ionis Adds Biopharma Veteran Ludwig Hantson As Commercial Phase Nears

Ionis Pharmaceuticals (NasdaqGS:IONS) has appointed Ludwig Hantson, Ph.D. to its Board of Directors. Dr. Hantson brings decades of global biopharmaceutical leadership experience from roles at Alexion, Baxter Bioscience/Baxalta, Novartis, and Johnson & Johnson. Ionis Pharmaceuticals focuses on RNA-targeted therapeutics, with several late-stage assets moving closer to potential commercial decisions. As the broader biotech sector continues to emphasize targeted and genetic medicines, the...